miRpredX 31-3p kit
The miRpredX 31-3p test kit is a simple, ready to use CE-IVD Marked kit that provides reagents to measure the expression level of the microRNA miR-31-3p in FFPE tumor samples using standard RTqPCR testing.
miR‐31‐3p and colorectal cancer
Colorectal cancer is third most common cancer in men and second most common in women with over 1.3 million new cases annually on a worldwide basis. An estimated 694,000 deaths from CRC occur worldwide every year, accounting for 8.5% of all cancer deaths and making it the fourth most common cause of death from cancer.
miR-31-3p Clinical data
miR-31-3p enables clinicians to identify RAS WT mCRC patients for which first-line anti-EGFR treatment will be of greater clinical benefit versus anti-VEGF therapy or when second or further lines of treatment with anti-EGFR therapy is beneficial to patients with RAS WT mCRC.
miR-31-3p presentation and publications
Studies demonstrating the association between miR-31-3p and survival in metastatic colorectal cancer have been published in peer-reviewed journals and presented at numerous scientific meetings.
IntegraGen's scientific advisory board for metastatic colorectal cancer includes world renown clinicians who represent both academic and community oncology. Our advisers provide us with valued insight and guidance on our efforts to develop oncology biomarkers which assist physicians to better manage cancer patients.
What are microRNA’s?